| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCRESAHA.110.216846 |
| P698 | PubMed publication ID | 20595654 |
| P50 | author | Hiromi Rakugi | Q35703947 |
| P2093 | author name string | Hideo Shimizu | |
| Ryuichi Morishita | |||
| Futoshi Nakagami | |||
| Hironori Nakagami | |||
| Munehisa Shimamura | |||
| Takashi Miyake | |||
| Nobutaka Koibuchi | |||
| Mariana Kiomy Osako | |||
| Hiroshi Koriyama | |||
| P433 | issue | 4 | |
| P921 | main subject | vascular calcification | Q54911504 |
| osteoporosis | Q165328 | ||
| estrogen | Q277954 | ||
| P304 | page(s) | 466-475 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification | |
| P478 | volume | 107 |
| Q39448176 | Absence of the Vitamin D Receptor Inhibits Atherosclerotic Plaque Calcification in Female Hypercholesterolemic Mice |
| Q88425523 | Activation of the non-canonical NF-κB/p52 pathway in vascular endothelial cells by RANKL elicits pro-calcific signalling in co-cultured smooth muscle cells |
| Q48156144 | Angiotensin II promotes an osteoblast-like phenotype in porcine aortic valve myofibroblasts |
| Q36738086 | Anti-inflammatory effects of a Chinese herbal medicine in atherosclerosis via estrogen receptor β mediating nitric oxide production and NF-κB suppression in endothelial cells |
| Q36928773 | Association analyses suggest the effects of RANK and RANKL on age at menarche in Chinese women. |
| Q40759651 | Association between the metabolome and bone mineral density in pre- and post-menopausal Chinese women using GC-MS. |
| Q36571983 | Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes |
| Q53039240 | BMP type I receptor inhibition attenuates endothelial dysfunction in mice with chronic kidney disease. |
| Q38057623 | Biomolecular mechanism of urinary stone formation involving osteopontin |
| Q38889423 | Bone loss and vascular calcification: A bi-directional interplay? |
| Q87186109 | CALibrating the CALumenin gene: New insights in overcoming the vascular CALcification CALamity? |
| Q89216879 | Calcific aortic stenosis |
| Q30503246 | Calcific aortic valve stenosis: methods, models, and mechanisms |
| Q34334592 | Coral reef aorta: case report and review of the literature |
| Q34230303 | Correlation between osteoporosis and cardiovascular disease |
| Q39357418 | Decrease in blood pressure and regression of cardiovascular complications by angiotensin II vaccine in mice |
| Q38832148 | Deletion of a Distal RANKL Gene Enhancer Delays Progression of Atherosclerotic Plaque Calcification in Hypercholesterolemic Mice. |
| Q51283005 | Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis. |
| Q36470803 | Enhanced mineralization potential of vascular cells from SM22α-Rankl (tg) mice |
| Q89847166 | Estrogen inhibits vascular calcification in rats via hypoxia-induced factor-1α signaling |
| Q34336346 | Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes |
| Q92279717 | Fibroblast growth factor 21; review on its participation in vascular calcification pathology |
| Q33555162 | Fibromodulin promoted in vitro and in vivo angiogenesis |
| Q35071037 | Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification |
| Q37003876 | GPR30 decreases with vascular aging and promotes vascular smooth muscle cells maintaining differentiated phenotype and suppressing migration via activation of ERK1/2 |
| Q85799027 | Implication of receptor activator of NF-κB ligand in Wnt/β-catenin pathway promoting osteoblast-like cell differentiation |
| Q40719297 | Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. |
| Q99730865 | Indoxyl sulfate promotes osteogenic differentiation of vascular smooth muscle cells by miR-155-5p-dependent downregulation of matrix Gla protein via ROS/NF-κB signaling |
| Q38475190 | Key genes associated with osteoporosis revealed by genome wide gene expression analysis |
| Q41477999 | LNGFR targets the Wnt/β-catenin pathway and promotes the osteogenic differentiation in rat ectomesenchymal stem cells |
| Q58363202 | Links Between Hypertension and Osteoporosis: Benidipine Ameliorates Osteoporosis in Ovariectomized Hypertensive Rats Through Promotion of Osteoblast Proliferation and Inhibition of Osteoclast Differentiation |
| Q36142207 | Mechanisms and clinical consequences of vascular calcification |
| Q26821993 | Mechanisms of arterial calcifications and consequences for cardiovascular function |
| Q51583712 | MicroRNA-34b/c inhibits aldosterone-induced vascular smooth muscle cell calcification via a SATB2/Runx2 pathway. |
| Q28087423 | Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature |
| Q96762033 | Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture |
| Q33730470 | OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice |
| Q33799132 | Oestrogen Inhibits Arterial Calcification by Promoting Autophagy |
| Q44791521 | Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. |
| Q46288096 | Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease |
| Q93039073 | Osteopontin in Bone Metabolism and Bone Diseases |
| Q38513410 | Osteoporosis and cardiovascular disease: an update |
| Q38034388 | Osteoporosis--a risk factor for cardiovascular disease? |
| Q30234828 | Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific? |
| Q30248402 | Pathophysiology-based treatment of urolithiasis. |
| Q37492019 | Phosphate: an old bone molecule but new cardiovascular risk factor |
| Q54361902 | Puerarin attenuates calcification of vascular smooth muscle cells. |
| Q64944581 | RANKL Inhibits the Production of Osteoprotegerin from Smooth Muscle Cells under Basal Conditions and following Exposure to Cyclic Strain. |
| Q89666841 | RANKL biology: bone metabolism, the immune system, and beyond |
| Q38872054 | RETRACTED: Analysis of protein-protein interaction network and functional modules on primary osteoporosis |
| Q34544781 | Rabbiteye blueberry prevents osteoporosis in ovariectomized rats |
| Q39347131 | Receptor activator of NF-κB ligand promotes proliferation of a putative mammary stem cell unique to the lactating epithelium. |
| Q52606512 | Regulation of Vascular Calcification by Growth Hormone-Releasing Hormone and its Agonists. |
| Q36309309 | Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification |
| Q38009712 | Skeletal and extraskeletal actions of denosumab. |
| Q47128807 | TRAIL attenuates RANKL-mediated osteoblastic signalling in vascular cell mono-culture and co-culture models. |
| Q34989869 | TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL. |
| Q38703771 | Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification |
| Q83810314 | The bone and beyond: a shift in calcium |
| Q53304059 | The function and meaning of receptor activator of NF-κB ligand in arterial calcification. |
| Q36111285 | The role of RANK ligand/osteoprotegerin in rheumatoid arthritis |
| Q38070658 | The role of fetuin-A in physiological and pathological mineralization |
| Q37922640 | The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review |
| Q35083231 | The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification |
| Q33668868 | Undercarboxylated osteocalcin reverts insulin resistance induced by endoplasmic reticulum stress in human umbilical vein endothelial cells |
| Q28078744 | Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke |
| Q38754124 | Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL. |
| Q35553833 | Vascular calcification: Mechanisms of vascular smooth muscle cell calcification |
Search more.